21 CFR Part 4 Compliance Program for Combination Products: US Quality System Roadmap in 2023 21 CFR Part 4 Compliance Program for Combination Products: US Quality System Roadmap in 2023 The regulatory landscape for combination products requires meticulous planning and compliance with various guidelines. The FDA combination product consulting process involves adhering to the stipulations outlined in 21 CFR Part 4, which provides a set of standards designed to harmonize the quality system requirements across multiple product categories. This article serves as a comprehensive step-by-step tutorial guide for regulatory affairs professionals navigating the complexities of 21 CFR Part 4 compliance….

Combination Product GMP Gap Assessment: Integrating 21 CFR 210/211 with Device QSR in 2023 Combination Product GMP Gap Assessment: Integrating 21 CFR 210/211 with Device QSR in 2023 The integration of Good Manufacturing Practices (GMP) for combination products can create regulatory challenges due to their unique status that encompasses both drug and device components. It is essential for organizations to conduct a comprehensive GMP gap assessment that aligns with both the FDA regulations under 21 CFR 210/211 for drugs, and the Quality System Regulation (QSR) for devices. This article will provide a step-by-step guide to achieving such an assessment. Step…

Human Factors Validation Plan for Autoinjectors and Prefilled Syringes: FDA Review Checklist in 2023 Human Factors Validation Plan for Autoinjectors and Prefilled Syringes: FDA Review Checklist in 2023 In the evolving landscape of drug-device combination products, the Human Factors Validation Plan (HFVP) stands as a pivotal component in the FDA review process. The HFVP not only facilitates the identification of potential user-related issues but also ensures the safety and effectiveness of autoinjectors and prefilled syringes. This step-by-step tutorial will guide regulatory affairs and quality assurance professionals through the necessary stages of developing an HFVP tailored for autoinjectors and prefilled syringes…

Combination Product Labeling Strategy: IFU, Carton, and Drug Label Alignment in 2023 Combination Product Labeling Strategy: IFU, Carton, and Drug Label Alignment in 2023 In the context of regulatory submissions for combination products, the alignment of Instructions for Use (IFU), carton labeling, and drug labeling is critical. Combination products are composed of more than one regulated component, such as a drug and a device. Consequently, they are subject to unique regulatory pathways that require careful consideration of all labeling elements. This article serves as a step-by-step tutorial guide aimed at regulatory affairs professionals navigating the complexities of combination product approvals…

Inspection Readiness for Combination Products: Audit Focus Areas and Evidence Packs in 2023 Inspection Readiness for Combination Products: Audit Focus Areas and Evidence Packs in 2023 Preparing for inspections of combination products is crucial for compliance with regulatory requirements set forth by the FDA and other international bodies. This guide provides a structured, step-by-step approach that outlines the key focus areas and documentation necessary for maintaining inspection readiness. Following these steps will help ensure that organizations are properly prepared for both internal audits and regulatory inspections. Step 1: Understanding Combination Products Regulations Combination products fall under a unique regulatory framework…

Commercial Launch Risk Controls for Combination Products: Supply Chain and Complaint Handling in 2023 Commercial Launch Risk Controls for Combination Products: Supply Chain and Complaint Handling in 2023 The commercialization of combination products presents unique challenges and potential risks that must be addressed carefully to ensure compliance with regulatory requirements. This tutorial provides a step-by-step guide for regulatory and quality assurance teams focusing on commercial launch risk controls specific to the supply chain and complaint handling for combination products in the United States. It emphasizes practical actions, documentation expectations, and alignment with FDA regulations. Step 1: Understanding the Regulatory Framework…